Chronic Kidney Disease–Mineral and Bone Disorder in Predialysis Diabetic Patients
European Journal of Clinical Pharmacy · 28.12.2025 · 7 (1) · 2489-2496
DOI: 10.61336/ejcp/25-01-281 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 28.12.2025. Verfasst von Kamran Lakhiar.
Abstract (Originalsprache)
Objectives: To investigate the frequency and biochemical constitution of CKD–MBD in predialysis diabetes patients, and determine its relationship with the stages of renal function. Study design and setting: This cross-sectional analytical study was conducted from 24TH October 2024 till 26th March 2025, at the Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan, among diabetic patients receiving standard outpatient nephrological care. Methodology: This cross-sectional study was conducted at the Sindh Institute of Urology and Transplantation (SIUT), Karachi, after ethical approval (ERC No. SIUT/NEPH/2024//574). A total of 231 stage 3–4 CKD patients aged 18–80 years were recruited using consecutive sampling. Serum calcium, phosphate, intact parathyroid hormone, vitamin D, and creatinine were measured, and eGFR was calculated using the CKD-EPI equation. CKD–MBD was defined per KDIGO 2017 criteria. Data were analyzed using SPSS v24, with p
Zitieren
APA
Lakhiar, K. (2025). Chronic Kidney Disease–Mineral and Bone Disorder in Predialysis Diabetic Patients. European Journal of Clinical Pharmacy, 7(1), 2489-2496. https://doi.org/10.61336/ejcp/25-01-281
Vancouver
Lakhiar K. Chronic Kidney Disease–Mineral and Bone Disorder in Predialysis Diabetic Patients. European Journal of Clinical Pharmacy. 2025;7(1):2489-2496. doi:10.61336/ejcp/25-01-281
BibTeX
@article{Lakhiar2025,
author = {Lakhiar, Kamran},
title = {Chronic Kidney Disease–Mineral and Bone Disorder in Predialysis Diabetic Patients},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {2489--2496},
doi = {10.61336/ejcp/25-01-281}
}
EUVIMED